Literature DB >> 22543702

Biphasic regulation of P-glycoprotein function and expression by NO donors in Caco-2 cells.

Ru Duan1, Nan Hu, Hai-yan Liu, Jia Li, Hai-fang Guo, Can Liu, Li Liu, Xiao-dong Liu.   

Abstract

AIM: To investigate the effects of nitric oxide (NO) donors on the function and expression of P-glycoprotein (P-gp) in Caco-2 cells.
METHODS: Caco-2 cells were exposed to NO donors for designated times. P-gp function and expression were assessed using Rhodamine123 uptake assay and Western blotting, respectively. Intracellular reactive oxygen species (iROS) and intracellular reactive nitrogen species (iRNS) levels were measured using ROS and RNS assay kits, respectively.
RESULTS: Exposure of Caco-2 cells to 0.1 or 2 mmol/L of sodium nitroprusside (SNP) affected the function and expression of P-gp in concentration- and time-dependent manners. A short-term (4 h) exposure reduced P-gp function and expression accompanied with significantly increased levels of iROS and iRNS. In contrast, a long-term (24 h) exposure stimulated the P-gp function and expression. The stimulatory effects of 2 mmol/L SNP was less profound as compared to those caused by 0.1 mmol/L SNP. The other NO donors SIN-1 and SNAP showed similar effects. Neither the NO scavenger PTIO (2 mmol/L) nor soluble guanylate cyclase inhibitor ODQ (50 μmol/L) reversed the SNP-induced alteration of P-gp function. On the other hand, free radical scavengers ascorbate, glutathione and uric acid (2 mmol/L for each), PKC inhibitor chelerythrine (5 μmol/L), PI3K/Akt inhibitor wortmannin (1 μmol/L) and p38 MAPK inhibitor SB203580 (10 μmol/L) reversed the upregulation of P-gp function by the long-term exposure to SNP, but these agents had no effect on the impaired P-gp function following the short-term exposure to SNP.
CONCLUSION: NO donors time-dependently regulate P-gp function and expression in Caco-2 cells: short-term exposure impairs P-gp function and expression, whereas long-term exposure stimulates P-gp function and expression. The regulation occurs via a NO-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22543702      PMCID: PMC4010373          DOI: 10.1038/aps.2012.25

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  37 in total

1.  Regulation of the reduced-folate transporter by nitric oxide in cultured human retinal pigment epithelial cells.

Authors:  S B Smith; W Huang; C Chancy; V Ganapathy
Journal:  Biochem Biophys Res Commun       Date:  1999-04-13       Impact factor: 3.575

Review 2.  Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development.

Authors:  Ferid Murad
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

Review 3.  Structure and function of cGMP-dependent protein kinases.

Authors:  A Pfeifer; P Ruth; W Dostmann; M Sausbier; P Klatt; F Hofmann
Journal:  Rev Physiol Biochem Pharmacol       Date:  1999       Impact factor: 5.545

4.  Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure.

Authors:  D Laouari; R Yang; C Veau; I Blanke; G Friedlander
Journal:  Am J Physiol Renal Physiol       Date:  2001-04

5.  Functional regulation of Na+-dependent neutral amino acid transporter ASCT2 by S-nitrosothiols and nitric oxide in Caco-2 cells.

Authors:  Tomomi Uchiyama; Yasuyuki Matsuda; Miyuki Wada; Satoru Takahashi; Takuya Fujita
Journal:  FEBS Lett       Date:  2005-04-25       Impact factor: 4.124

6.  Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier.

Authors:  Björn Bauer; Anika M S Hartz; David S Miller
Journal:  Mol Pharmacol       Date:  2006-11-28       Impact factor: 4.436

7.  The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity.

Authors:  R B Kean; S V Spitsin; T Mikheeva; G S Scott; D C Hooper
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

8.  Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux.

Authors:  Chiara Riganti; Erica Miraglia; Daniele Viarisio; Costanzo Costamagna; Gianpiero Pescarmona; Dario Ghigo; Amalia Bosia
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

9.  Nitric oxide mediates increased P-glycoprotein activity in interferon-{gamma}-stimulated human intestinal cells.

Authors:  Santosh G Dixit; Basilia Zingarelli; Donna J Buckley; Arthur R Buckley; Giovanni M Pauletti
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-10-14       Impact factor: 4.052

10.  Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats.

Authors:  Haiyan Liu; Xiao Xu; Zhihong Yang; Yuanxiong Deng; Xiaodong Liu; Lin Xie
Journal:  Brain Res       Date:  2006-10-30       Impact factor: 3.252

View more
  5 in total

1.  Effect of Nitric Oxide on the Functioning of the P-Glycoprotein Transporter.

Authors:  Yu V Abalenikhina; E A Sudakova; A A Slepnev; A V Shchul'kin; E N Yakusheva
Journal:  Bull Exp Biol Med       Date:  2022-05-28       Impact factor: 0.804

2.  Uremic Toxins Induce ET-1 Release by Human Proximal Tubule Cells, which Regulates Organic Cation Uptake Time-Dependently.

Authors:  Carolien M S Schophuizen; Joost G J Hoenderop; Rosalinde Masereeuw; Lambert P van den Heuvel
Journal:  Cells       Date:  2015-06-26       Impact factor: 6.600

Review 3.  Alterations in function and expression of ABC transporters at blood-brain barrier under diabetes and the clinical significances.

Authors:  Li Liu; Xiao-Dong Liu
Journal:  Front Pharmacol       Date:  2014-12-10       Impact factor: 5.810

4.  The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells.

Authors:  Chun Ge; Bei Cao; Dong Feng; Fang Zhou; Jingwei Zhang; Na Yang; Siqi Feng; Guangji Wang; Jiye Aa
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

Review 5.  Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance.

Authors:  Yiting Yang; Xiaodong Liu
Journal:  Pharmaceutics       Date:  2020-04-11       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.